Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary

Chandrakasan, S., Allen, C. E., Bhatla, D., Carter, J., Chien, M., Cooper, R., Draper, L., Eckstein, O. S., Hanna, R., Hays, J. A., Hermiston, M. L., Hinson, A. P., Hobday, P. M., Isakoff, M. S., Jordan, M. B., Leiding, J. W., Modica, R., Nakano, T. A., … Oladapo, A. (2025). Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary. Immunotherapy, 17(7), 461–478. https://doi.org/10.1080/1750743x.2025.2509478
Authors:
Shanmuganathan Chandrakasan
Carl E. Allen
Deepika Bhatla
John Carter
May Chien
Robert B. Cooper
Lauren Draper
Olive S. Eckstein
Rabi Hanna
J. Allyson Hays
Michelle L. Hermiston
Ashley P. Hinson
Patricia M. Hobday
Michael S. Isakoff
Michael B. Jordan
Jennifer W. Leiding
Renee Modica
Taizo A. Nakano
Abiola Oladapo
Sachit Patel
Priti Pednekar
Mona Riskalla
Susmita N. Sarangi
Prakash Satwani
Anand Tandra
Kelly Walkovich
John Yee
Adi Zoref‐Lorenz
Edward M. Behrens
Affiliated Authors:
Prakash Satwani
Columbia Affiliation:
Subjects:
Hemophagocytic Lymphohistiocytosis and Related Disorders (OpenAlex Topic)
Supporting Health Care Transition from Adolescence to Adulthood (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1080/1750743x.2025.2509478
PMID:
40528399
DOI:
10.1080/1750743x.2025.2509478
Journal:
Immunotherapy
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: